Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
82.54
-0.76 (-0.91%)
At close: Jul 31, 2026, 4:00 PM EDT
82.57
+0.03 (0.04%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Halozyme Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,508 | 1,397 | 1,015 | 829.25 | 660.12 | 443.31 |
Revenue Growth | 39.12% | 37.55% | 22.44% | 25.62% | 48.91% | 65.66% |
Gross Profit Gross Profit Growth | 1,249 | 1,168 | 855.91 | 636.89 | 520.81 | 361.9 |
Operating Income Operating Income Growth | 511.99 | 469.01 | 551.48 | 337.57 | 267.53 | 275.9 |
Net Income Net Income Growth | 348.84 | 316.89 | 444.09 | 281.59 | 202.13 | 402.71 |
Earnings Per Share EPS Growth | 2.78 | 2.56 | 3.43 | 2.10 | 1.44 | 2.74 |
EPS Growth | -26.06% | -25.36% | 63.33% | 45.83% | -47.45% | 201.10% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Royalties Royalties Growth | 940.33 | 867.84 | 570.99 | 447.87 | 360.48 | 203.9 |
Sales of Proprietary Products Sales of Proprietary Products Growth | 200.14 | 194.61 | 166.62 | 130.83 | 72.85 | 23.26 |
Sales of Bulk rHuPH20 Sales of Bulk rHuPH20 Growth | 179.5 | 133.02 | 86.33 | 115.44 | 82.08 | 80.96 |
Sales of Device Partnered Products Sales of Device Partnered Products Growth | 49.19 | 48.81 | 50.54 | 54.58 | 36.1 | - |
Revenue Under Collaborative Agreements Revenue Under Collaborative Agreements Growth | 139.3 | 152.33 | 140.84 | 80.53 | 108.61 | 135.19 |
Revenue (Total) Revenue (Total) Growth | 1,508 | 1,397 | 1,015 | 829.25 | 660.12 | 443.31 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 318.62 | 142.82 | 596.07 | 336 | 362.79 | 740.92 |
Total Debt Total Debt Growth | 2,145 | 2,143 | 1,506 | 1,499 | 1,506 | 876.67 |
Net Cash (Debt) Net Cash Growth | -1,826 | -2,000 | -909.72 | -1,163 | -1,143 | -135.75 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.00 | -16.14 | -7.03 | -8.67 | -8.13 | -0.92 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 677.42 | 651.56 | 479.06 | 388.57 | 240.11 | 299.44 |
Capital Expenditures CapEx Growth | -9.76 | -6.97 | -10.7 | -15.29 | -4.81 | -1.46 |
Free Cash Flow Free Cash Flow Growth | 667.65 | 644.59 | 468.37 | 373.28 | 235.3 | 297.98 |
Free Cash Flow Growth | 34.67% | 37.62% | 25.47% | 58.64% | -21.04% | 462.76% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 82.79% | 83.62% | 84.30% | 76.80% | 78.90% | 81.64% |
Operating Margin | 33.94% | 33.58% | 54.32% | 40.71% | 40.53% | 62.24% |
Pretax Margin | 33.37% | 33.43% | 54.87% | 42.01% | 37.71% | 56.06% |
Profit Margin | 23.13% | 22.69% | 43.74% | 33.96% | 30.62% | 90.84% |
FCF Margin | 44.26% | 46.15% | 46.13% | 45.01% | 35.65% | 67.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.05 | 26.29 | 13.94 | 17.60 | 39.51 | 14.68 |
Forward PE | 9.41 | 8.85 | 10.38 | 9.77 | 21.92 | 17.89 |
P/FCF Ratio | 14.66 | 12.30 | 12.57 | 12.55 | 32.68 | 18.55 |
PS Ratio | 6.49 | 5.68 | 5.80 | 5.65 | 11.65 | 12.47 |